Publications by authors named "Kalliopi Diakaki"
Article Synopsis
- Schizophrenia is a long-term mental health condition that severely affects a person’s daily life, and treatments usually combine medication and therapy, but many patients do not respond well to existing options.
- Recent research has identified ten new drugs aimed at treating schizophrenia, including three that have been approved by the FDA, while others are still being tested in clinical trials.
- There is a need for more research to better understand the causes of schizophrenia and create effective treatments that address negative and cognitive symptoms without causing negative side effects from current medications.
Health professionals have been at the frontline of the health service since the outbreak of covid-19, responding promptly to diagnose, support and treat infected patients. World Health Organization (WHO) has already praised their contribution and their essential role in controlling this disease. Some of the main concerns of covid-19's impact to health service staff include work overload, exhaustion, and high risk of self-infection or transmission to family members.
View Article and Find Full Text PDF